Roche receives FDA Approval for novel PD-L1 biomarker assay

TUCSON, Ariz., May 18, 2016 /PRNewswire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced approval of the VENTANA PD-L1 (SP142) Assay1 by the US Food and Drug Administration (FDA) as a complementary diagnostic to provide PD-L1 status on patients who are considering treatment… http://www.prnewswire.com/news-releases/roche-receives-fda-approval-for-novel-pd-l1-biomarker-assay-300271074.html